QEO
- Product code
- QEO
- Device name
- Light Attenuation Lenses For Migraine-Associated Light Sensitivity
- Device class
- Class 1
- 21 CFR
- 21 CFR 882.5811
- Medical specialty
- Neurology
- Marketing pathway
- 510(K) Exempt
- 510(k) clearances (last 3 years)
- 1
FDA classification definition
Light attenuation lenses for migraine-associated light sensitivity are devices that limit light incidence of specific wavelengths to the eyes and are intended to decrease the impact of light sensitivity in patients diagnosed with migraine. The lenses can be mounted on a spectacle frame, clips, or other apertures used to hold lenses. The device is intended to be adjunctive to other therapies for migraine-associated light sensitivity. Sunglasses (nonprescription) and prescription spectacle lenses are separately classified under § 886.5850 and § 886.5844, respectively.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name |
|---|---|---|---|
| DEN250026 | 2026-08-21 | Matap Ii, LLC | Avulux |
Official FDA classification page: QEO
Classification and pathway per current FDA publications. Data from openFDA (CC0).